These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30765243)

  • 1. Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study.
    Diallo MSK; Rabilloud M; Ayouba A; Touré A; Thaurignac G; Keita AK; Butel C; Kpamou C; Barry TA; Sall MD; Camara I; Leroy S; Msellati P; Ecochard R; Peeters M; Sow MS; Delaporte E; Etard JF;
    Lancet Infect Dis; 2019 Mar; 19(3):308-316. PubMed ID: 30765243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study.
    Etard JF; Sow MS; Leroy S; Touré A; Taverne B; Keita AK; Msellati P; Magassouba N; Baize S; Raoul H; Izard S; Kpamou C; March L; Savane I; Barry M; Delaporte E;
    Lancet Infect Dis; 2017 May; 17(5):545-552. PubMed ID: 28094208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study.
    Diallo MSK; Ayouba A; Keita AK; Thaurignac G; Sow MS; Kpamou C; Barry TA; Msellati P; Etard JF; Peeters M; Ecochard R; Delaporte E; Toure A;
    Lancet Microbe; 2021 Dec; 2(12):e676-e684. PubMed ID: 35544108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey.
    Timothy JWS; Hall Y; Akoi-Boré J; Diallo B; Tipton TRW; Bower H; Strecker T; Glynn JR; Carroll MW
    Lancet Infect Dis; 2019 Apr; 19(4):429-438. PubMed ID: 30799252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
    Thom R; Tipton T; Strecker T; Hall Y; Akoi Bore J; Maes P; Raymond Koundouno F; Fehling SK; Krähling V; Steeds K; Varghese A; Bailey G; Matheson M; Kouyate S; Coné M; Moussa Keita B; Kouyate S; Richard Ablam A; Laenen L; Vergote V; Guiver M; Timothy J; Atkinson B; Ottowell L; Richards KS; Bosworth A; Longet S; Mellors J; Pannetier D; Duraffour S; Muñoz-Fontela C; Sow O; Koivogui L; Newman E; Becker S; Sprecher A; Raoul H; Hiscox J; Henao-Restrepo AM; Sakoba K; Magassouba N; Günther S; Kader Konde M; Carroll MW
    Lancet Infect Dis; 2021 Apr; 21(4):507-516. PubMed ID: 33065039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus.
    Glynn JR; Bower H; Johnson S; Houlihan CF; Montesano C; Scott JT; Semple MG; Bangura MS; Kamara AJ; Kamara O; Mansaray SH; Sesay D; Turay C; Dicks S; Wadoum REG; Colizzi V; Checchi F; Samuel D; Tedder RS
    Lancet Infect Dis; 2017 Jun; 17(6):645-653. PubMed ID: 28256310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsequent mortality in survivors of Ebola virus disease in Guinea: a nationwide retrospective cohort study.
    Keita M; Diallo B; Mesfin S; Marega A; Nebie KY; Magassouba N; Barry A; Coulibaly S; Barry B; Baldé MO; Pallawo R; Sow S; Bah AO; Balde MS; Van Gucht S; Kondé MK; Diallo AB; Djingarey MH; Fall IS; Formenty P; Glynn JR; Subissi L
    Lancet Infect Dis; 2019 Nov; 19(11):1202-1208. PubMed ID: 31494017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study.
    Faye O; Boëlle PY; Heleze E; Faye O; Loucoubar C; Magassouba N; Soropogui B; Keita S; Gakou T; Bah el HI; Koivogui L; Sall AA; Cauchemez S
    Lancet Infect Dis; 2015 Mar; 15(3):320-6. PubMed ID: 25619149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals.
    Herrera BB; Hamel DJ; Oshun P; Akinsola R; Akanmu AS; Chang CA; Eromon P; Folarin O; Adeyemi KT; Happi CT; Lu Y; Ogunsola F; Kanki PJ
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006530. PubMed ID: 29795572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Ebola virus disease on maternal and child health services in Guinea: a retrospective observational cohort study.
    Delamou A; Ayadi AME; Sidibe S; Delvaux T; Camara BS; Sandouno SD; Beavogui AH; Rutherford GW; Okumura J; Zhang WH; De Brouwere V
    Lancet Glob Health; 2017 Apr; 5(4):e448-e457. PubMed ID: 28237252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.
    Mulangu S; Alfonso VH; Hoff NA; Doshi RH; Mulembakani P; Kisalu NK; Okitolonda-Wemakoy E; Kebela BI; Marcus H; Shiloach J; Phue JN; Wright LL; Muyembe-Tamfum JJ; Sullivan NJ; Rimoin AW
    J Infect Dis; 2018 Jan; 217(4):529-537. PubMed ID: 29329455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola virus circulation in a non-epidemic Guinean rural area: A mixed-method approach to assessing endemicity.
    Hounmenou CG; Marcis FL; Kaba D; Diaby M; Soumah AK; Diallo H; Thaurignac G; Camara SC; Ayouba A; Peeters M; Keita AK; Delaporte E; Touré A
    Int J Infect Dis; 2024 Sep; 146():107129. PubMed ID: 38908818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.
    Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; Diallo MSK; Mukadi-Bamuleka D; Kitenge R; Formenty P; Legand A; Edidi-Atani F; Thaurignac G; Pelloquin R; Mbala-Kingebeni P; Toure A; Ayouba A; Muyembe-Tamfum JJ; Delaporte E; Peeters M; Ahuka-Mundeke S;
    Lancet Infect Dis; 2024 Mar; 24(3):266-274. PubMed ID: 38043556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.
    Richardson ET; Kelly JD; Barrie MB; Mesman AW; Karku S; Quiwa K; Marsh RH; Koedoyoma S; Daboh F; Barron KP; Grady M; Tucker E; Dierberg KL; Rutherford GW; Barry M; Jones JH; Murray MB; Farmer PE
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005087. PubMed ID: 27846221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.
    Sissoko D; Duraffour S; Kerber R; Kolie JS; Beavogui AH; Camara AM; Colin G; Rieger T; Oestereich L; Pályi B; Wurr S; Guedj J; Nguyen THT; Eggo RM; Watson CH; Edmunds WJ; Bore JA; Koundouno FR; Cabeza-Cabrerizo M; Carter LL; Kafetzopoulou LE; Kuisma E; Michel J; Patrono LV; Rickett NY; Singethan K; Rudolf M; Lander A; Pallasch E; Bockholt S; Rodríguez E; Di Caro A; Wölfel R; Gabriel M; Gurry C; Formenty P; Keïta S; Malvy D; Carroll MW; Anglaret X; Günther S
    Lancet Glob Health; 2017 Jan; 5(1):e80-e88. PubMed ID: 27955791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
    Henao-Restrepo AM; Longini IM; Egger M; Dean NE; Edmunds WJ; Camacho A; Carroll MW; Doumbia M; Draguez B; Duraffour S; Enwere G; Grais R; Gunther S; Hossmann S; Kondé MK; Kone S; Kuisma E; Levine MM; Mandal S; Norheim G; Riveros X; Soumah A; Trelle S; Vicari AS; Watson CH; Kéïta S; Kieny MP; Røttingen JA
    Lancet; 2015 Aug; 386(9996):857-66. PubMed ID: 26248676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.
    Houlihan CF; McGowan CR; Dicks S; Baguelin M; Moore DAJ; Mabey D; Roberts CH; Kumar A; Samuel D; Tedder R; Glynn JR
    PLoS Med; 2017 May; 14(5):e1002300. PubMed ID: 28510604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network visualization for outbreak response: Mapping the Ebola Virus Disease (EVD) chains of transmission in N'Zérékoré, Guinea.
    Valencia C; Bah H; Fatoumata B; Rodier G; Diallo B; Koné M; Giese C; Conde L; Malano E; Mollet T; Jansa J; Coulombier D; Sudre B
    J Infect; 2017 Mar; 74(3):294-301. PubMed ID: 27840270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection.
    Rimoin AW; Lu K; Bramble MS; Steffen I; Doshi RH; Hoff NA; Mukadi P; Nicholson BP; Alfonso VH; Olinger G; Sinai C; Yamamoto LK; Ramirez CM; Okitolonda Wemakoy E; Kebela Illunga B; Pettitt J; Logue J; Bennett RS; Jahrling P; Heymann DL; Piot P; Muyembe-Tamfum JJ; Hensley LE; Simmons G
    J Infect Dis; 2018 Jan; 217(2):223-231. PubMed ID: 29253164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.
    Mulangu S; Borchert M; Paweska J; Tshomba A; Afounde A; Kulidri A; Swanepoel R; Muyembe-Tamfum JJ; Van der Stuyft P
    BMC Infect Dis; 2016 Jun; 16():263. PubMed ID: 27286990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.